Cerus Corp stock is traded at $1.85, with a volume of 4,512,961. It is down -2.63% in the last 24 hours and down -19.91% over the past month. Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
Previous Close:
$1.90
Open:
$1.84
24h Volume:
4,512,961
Relative Volume:
1.16
Market Cap:
$373.62M
Revenue:
$216.56M
Net Income/Loss:
-$9.57M
P/E Ratio:
-
EPS:
-$0.0497
Net Cash Flow:
-$1.22M
1W Performance:
-6.80%
1M Performance:
-19.91%
6M Performance:
-31.23%
1Y Performance:
+24.16%
1-Day Range:
$1.82$1.95
1-Week Range:
$1.82$2.09
52-Week Range:
$1.47$3.47
Cerus Corp Stock (CERS) Company Profile
Name
Cerus CorpSector
HealthcareIndustry
Medical DevicesPhone
(925) 288-6000Address
1220 CONCORD AVENUE, CONCORD, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS